This high prevalence in our SCZ cohort of relatively large ∼100–500-kb deletions, and the known involvement of germline NRXN1 mutations in SCZ and other neurodevelopmental disorders, suggests that mosaic deletions of exons 1–5 might also contribute to SCZ risk. The gene discussed is NRXN1; the disease is neurodevelopmental disorder.